Latest

Latest antibody News | Page 3

  • Latest antibody news stories and updates. What is happening today? All recent antibody news and developments. Live coverage and timeline of antibody. All you need to know about antibody.
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Update on brazikumab development programme
Making Vaccines Longer Lasting
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
Novel Regulatory Mechanism of Blood Clotting Discovered
Patrys’ says preclinical data supports synthetic lethality mechanism
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
CSL reports positive results from pivotal late-stage trial of first-in-class garadacimab
TGA provisionally approves Moderna’s new bivalent Covid vaccine
TGA grants provisional approval to Moderna’s COVID-19 bivalent (SPIKEVAX Bivalent Original/Omicron BA.4-5) booster dose vaccine
TGA grants provisional approval to Pfizer’s COVID-19 bivalent (COMIRNATY Original/Omicron BA.4-5 COVID-19 vaccine) booster dose vaccine
WHO updates COVID-19 guidelines on masks, treatments and patient care
Exploring air we breathe
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Anatomical barriers shield brain from SARS-CoV-2 invasion at vulnerable interfaces
Enhertu achieved statistically significant overall survival, reducing risk of death by 36% vs. trastuzumab emtansine
Australian venture capital fund joins partners in backing new immunotherapy
AstraZeneca aims to redefine breast cancer care with new data across treatment spectrum at SABCS 2022
CSL and Translational Sciences enter Agreement
Dr Michelle Boyle named 2023 CSL Centenary Fellow
NATURE publishes data on DUNP19 receptors role in cancer growth
Live Intracellular Imaging with New, Conditionally Active Immunofluorescence Probe
Enhertu continues to demonstrate clinically meaningful tumour response
TGA provisionally approves Moderna bivalent Covid vaccine for use as booster dose in adults
CSL starts planning to submit new antibody treatment
CSL Announces Positive Results for Garadacimab
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Starpharma announces new research agreement for DEP drug delivery platform
Datopotamab deruxtecan-based combinations show promising clinical activity
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Interim statement on composition of current Covid vaccines
Enhertu reduced risk of disease progression or death by 50% vs. chemotherapy
Secrets of thymus formation revealed
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
TGA receives application for an increased dose of GlaxoSmithKline’s Covid treatment sotrovimab for BA.2 Omicron sublineage
QuickStart to treatment for hepatitis C
More COVID medicines for most at-risk New Zealanders
Fewer antibody diversity as we age
There is more to Sars-CoV-2 than meets eye
New mathematical model predicts effectiveness of Covid vaccines
WHO updates its treatment guidelines to include molnupiravir
Patrys selects stable cell line for production of PAT-DX3
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial
WHO prequalifies first monoclonal antibody – tocilizumab – to treat Covid
Exercise post-vaccine bumps up antibodies
Covid community surveillance project launches

© 2026 - The National Tribune Australia